This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Catheter-Based Treatments

September 27, 2017
The authors analyzed their prospective hospital TAVR register to assess whether the addition of serum albumin as a marker of frailty would improve the ability of the STS and EuroSCORE-2 scores to predict mortality.  TAVR patients were divided into 4 groups based on median serum albumin and median STS and EuroSCORE-2 values. 
September 12, 2017
Vets have performed life-saving heart surgery on what is believed to be the smallest dog to undergo the procedure.
April 29, 2017
A succinct update relevant to all arrhythmia and heart failure surgeons. The concept of atrial cardiomyopathy is particularly stimulating.
February 13, 2017
The authors report on an echocardiographic sub-study of the NOTION trial, a prospective randomized study which compared outcomes between 120 patients undergoing TAVI and 112 patients undergoing aortic valve replacement (AVR).
December 27, 2016
The authors report on their findings an ongoing Japanese multicentre prospective registry. They evaluate outcomes in 478 patients undergoing transfemoral  TAVI and treated with percutaneous puncture using an expandable sheath, Edwards Sapien XTprosthesis and a Perclose ProGlide system.
September 27, 2016
This analysis of PARTNER data evaluated the impact of chronic kidney disease (CKD) on outcomes after TAVR.  Patients were grouped according to GFR as none/mild, moderate, and severe renal disease.  Severe disease was most common among women with diabetes.
July 25, 2016
The authors describe their findings in a multicenter retrospective review of clinical outcomes in 64 patients with severe mitral annular calcification considered poor candidates for traditional surgical mitral valve replacement, undergoing transcatheter mitral valve implantation with a balloon expandable prosthesis.
July 14, 2016
This article explores the controversial topic of TAVR versus surgical AVR in low-risk patients.  The primary outcome was 3-year survival.  The authors report 3-year survival for TAVR and surgical AVR as 72% and 83.4%, respective (p=0.0015).  Although TAVR is an exciting technology, there should be caution in adopting it in lower risk patients.  
June 28, 2016
This article investigates the effects of varying degrees of aortic regurgitation (AR) on survival after transcatheter aortic valve replacement (TAVR).  They retrospectively evaluated a cohort of 237 patients undergoing TAVR from 2006 to 2012 with echocardiogram performed within 30 days of the procedure.  Using a Cox proportional multivariable regress